154 related articles for article (PubMed ID: 11735420)
1. Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP.
Gobinet J; Auzou G; Nicolas JC; Sultan C; Jalaguier S
Biochemistry; 2001 Dec; 40(50):15369-77. PubMed ID: 11735420
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the androgen receptor and a segment of its corepressor SHP.
Jouravel N; Sablin E; Arnold LA; Guy RK; Fletterick RJ
Acta Crystallogr D Biol Crystallogr; 2007 Nov; 63(Pt 11):1198-200. PubMed ID: 18007036
[TBL] [Abstract][Full Text] [Related]
6. SHP represses transcriptional activity via recruitment of histone deacetylases.
Gobinet J; Carascossa S; Cavaillès V; Vignon F; Nicolas JC; Jalaguier S
Biochemistry; 2005 Apr; 44(16):6312-20. PubMed ID: 15835920
[TBL] [Abstract][Full Text] [Related]
7. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
Ikonen T; Palvimo JJ; Jänne OA
J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
[TBL] [Abstract][Full Text] [Related]
9. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
10. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
11. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
Johansson L; Båvner A; Thomsen JS; Färnegårdh M; Gustafsson JA; Treuter E
Mol Cell Biol; 2000 Feb; 20(4):1124-33. PubMed ID: 10648597
[TBL] [Abstract][Full Text] [Related]
12. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
13. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
14. Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.
Steketee K; Berrevoets CA; Dubbink HJ; Doesburg P; Hersmus R; Brinkmann AO; Trapman J
Eur J Biochem; 2002 Dec; 269(23):5780-91. PubMed ID: 12444966
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
[TBL] [Abstract][Full Text] [Related]
16. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
[TBL] [Abstract][Full Text] [Related]
17. Novel receptor interaction and repression domains in the orphan receptor SHP.
Seol W; Chung M; Moore DD
Mol Cell Biol; 1997 Dec; 17(12):7126-31. PubMed ID: 9372944
[TBL] [Abstract][Full Text] [Related]
18. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
Askew EB; Minges JT; Hnat AT; Wilson EM
Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
[TBL] [Abstract][Full Text] [Related]
20. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.
Schaufele F; Carbonell X; Guerbadot M; Borngraeber S; Chapman MS; Ma AA; Miner JN; Diamond MI
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9802-7. PubMed ID: 15994236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]